揭示SARS-CoV-2对血液静止和补充系统的影响:一个系统免疫学观点
Didar Murad1, Rehan Zafar Paracha1, Maryum Nisar1
1School of Interdisciplinary Engineering and Sciences (SINES), Department of Sciences, National University of Sciences and Technology (NUST), Islamabad, Pakistan.
Frontiers in immunology
|January 31, 2025
概括
这项研究模拟了COVID-19中的静血和补充系统,揭示了调节者如何影响疾病以及药物如何恢复平衡. 向血素,等离子体和C5b-9显示了治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 系统生物学 系统生物学
- 计算生物学 计算生物学
背景情况:
- 静血和补体系统对于免疫力和循环完整性至关重要.
- 这些系统的失调与严重的COVID-19并发症有关.
- 了解它们复杂的平衡对于治疗的发展至关重要.
研究的目的:
- 量化建模COVID-19中静血和补充系统之间的相互作用.
- 调查降低监管水平和药物干预对系统动态的影响.
- 确定治疗策略的关键分子标.
主要方法:
- 开发一个定量系统免疫学模型.
- 模拟疾病状态,干预的疾病状态和药物干预 (肝素,三胺酸,阿夫多拉利马布,加拉达西马布,托西利祖马布).
- 对关键成分动态的分析,包括血栓素,等离子素,IL-6和C5b-9.
主要成果:
- 降低补充调节剂 (H因子,C1抑制剂) 显著提升关键成分.
- 药物干预表明对系统调节失调有恢复作用.
- 在疾病进展早期准血栓素,等离子素和C5b-9显示出有前途.
结论:
- 这项研究阐明了控制静血和补充系统的调节机制.
- 生物通路机制维持了激活和抑制之间的平衡.
- 这些发现为设计针对COVID-19中这些相互连接系统的新疗法提供了基础.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K
Humoral Immune Responses
71.2K
Overview
71.2K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K
Antimicrobial Proteins
877
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
877
Disorders of Hemostasis
688
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
688


